The Promising Effect of Tocilizumab on Chronic Antibody-Mediated Rejection (cAMR) of Kidney Transplant

<b>Background</b>: Chronic antibody-mediated rejection (cAMR) constitutes a serious challenge in the long-term success of organ transplantation. It is associated with donor-specific antibodies (DSAs) which activate a complement pathway in response to the presence of human leukocyte antig...

Full description

Bibliographic Details
Published in:Pharmaceutics
Main Authors: Łukasz Świątek, Miłosz Miedziaszczyk, Dominik Lewandowski, Filip Robakowski, Piotr Tyburski, Marta Jakubowska, Marek Karczewski, Ilona Idasiak-Piechocka
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Subjects:
cAMR
DSA
eGFR
kidney rejection
tocilizumab
Online Access:https://www.mdpi.com/1999-4923/17/1/78

Internet

https://www.mdpi.com/1999-4923/17/1/78

Similar Items